The SWAN Impact Network is pleased to announce an investment in Eisana.
Eisana prevents the nerve damage caused by chemotherapy by cooling hands and feet via an innovative, effective, patient-friendly device which improves quality of life for patients post cancer treatment.
SWAN is pleased to announce that Goodwin Procter LLP has joined SWAN as our newest sponsor.
Goodwin’s nearly 2,000 lawyers focus on building authentic, long-term relationships with clients, who are some of the world’s most successful and innovative investors, entrepreneurs, and disruptors at the convergence of and within the life sciences, private equity, real estate, technology, and financial industries. Their immersive understanding of their clients’ industries – combined with their expertise across high-stakes litigation and dispute resolution, world-class regulatory compliance and advisory services, and complex transactions – sets them apart. Goodwin Law has offices in various cities in North America, Europe, and Asia.
Despite the economic uncertainties experienced by our angel investors in 2022, they
stepped up and invested in eleven social or environmental impact companies. SWAN angels are committed to making the world a better place.
SWAN’s investments enable creative entrepreneurs to
address important United Nations Sustainable Development Goals.
The SWAN Impact Network’s portfolio significantly increased in value in 2022.
And SWAN established a Philanthropic Fund that allows charitable
donations to be invested in companies that have been funded by SWAN angels.
In 2022, SWAN added to its broad alliance of impact and syndication partners.
The SWAN Impact Network is pleased to announce an investment in Pure Blue Tech.
Pure Blue Tech’s membrane technology reduces membrane fouling which enables efficient water generation and lowers the cost to filter and purify water, wastewater, seawater and other liquids via its self-cleaning membrane elements.
The SWAN Impact Network is pleased to announce an investment in Pecos Wind Power.
Pecos designs and builds low-wind-optimized, community-scale wind turbines which enables more customers to access renewable electricity.
The SWAN Impact Network is pleased to announce an investment in Nano PharmaSolutions.
Nano PharmaSolutions helps pharma companies to rapidly advance to the first-in-human clinical stage by making new drugs more soluble and human bio-available.
The SWAN Impact Network is pleased to announce an investment in Imperium Technologies.
Imperium improves the efficiency of steam transmission through pipes and reduces unnecessary greenhouse gas emissions with its real-time monitoring capabilities and reliable steam trap design.
Congratulations to SWAN portfolio company Yotta Energy, which was recently selected as one of 10 companies to participate in The Clean Fight New York. The Clean Fight New York is a not-for-profit climate tech organization, powered by New Energy Nexus, that helps scale growth-stage climate tech companies in New York. The third chapter of The Clean Fight is focused on battery and energy storage solutions that can help speed the clean energy transition.
Yotta Energy has been selected by the New York State Energy Research and Development Authority and the U.S. Department of Energy as one of ten climate tech companies, hailing from Europe, Australia, North America and across the U.S, that are dedicated to significantly accelerating the move to a resilient, electrified, and clean economy, in New York and beyond.
Working across the value chain, these transformative companies are positioned for scale and ready to make an impact, with solutions ranging from cells and packs; thermal, long-duration, stationary and portable storage; mobility solutions; and distributed energy resources.
Austin, Texas-based Yotta Energy produces distributed energy products, including EV chargers and the first solar battery that integrates behind rooftop solar panels. The integrated battery significantly reduces installation costs, along with its plug-and-play design that means if you can install a solar module, you can install their battery.
SWAN is pleased to announce an initial investment in Relavo.
Relavo is a medical device company that is changing the way that kidney failure patients receive treatment. Founded by an all-female team of biomedical engineers from Johns Hopkins University, Relavo is seeking to make home dialysis more accessible by minimizing the risk of infection with their technology, the PeritoneX. The PeritoneX is a novel connection device that reduces the risk of infection in peritoneal dialysis. Rather than connecting tubes directly, patients will connect them to the PeritoneX, which then internally disinfects the connected tubes with an antimicrobial solution. By reducing the risk of infection, patients will receive safer treatment.